Cost-effectiveness of atrial fibrillation therapy.
Heim
S W
SW
heims@health.missouri.edu
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000191:economics / Q000627:therapeutic use; D000925:Anticoagulants / Q000191:economics / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000191:economics* / Q000628:therapy*; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D004554:Electric Countershock / Q000191:economics; D006801:Humans; D008297:Male; D008962:Models, Theoretical; D015203:Reproducibility of Results; D015912:Thrombolytic Therapy / Q000191:economics
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants